Private Equity
PE firms move slowly into offense mode amid the coronavirus crisis and Thoma Bravo shelves its sale of Imprivata.
4 min read · 26 March 2020
Despite the current coronavirus crisis, deals are being prepped.
3 min read · 26 March 2020
Pathlight, a provider of a power team management platform, has secured $7 million in Series A funding.
3 min read · 26 March 2020
Demand for sextech, gambling and cannabis products began to skyrocket when lockdowns began.
2 min read · 26 March 2020
As one of few to lock down financing amidst the covid-19 turmoil, the PE firm’s specialty materials company Kymera manages to clinch a sizable add-on.
2 min read · 25 March 2020
Analysts predict a global seed slowdown of 22% by the end of Q1 because of the covid-19 outbreak, US seed investors say not so fast.
4 min read · 25 March 2020
Thomas Friedman recently argued that “the coronavirus will create a new historical divide: before-Corona (BC) and after-Corona (AC).”
3 min read · 25 March 2020
Across the private equity industry, the impacts of the pandemic-spurred economic downturn are being felt in dealmaking, which has slowed or paused fundraising processes while LPs work to understand the status of their portfolios.
1 min read · 25 March 2020
COVID-19 crisis could bode well for new M&A tech opportunities and Gryphon launches sixth fund.
3 min read · 25 March 2020
Market volatility has led to stalled deals, the withdrawal of sellers and the return of MAC clauses.
4 min read · 25 March 2020
